Brief: Quantum Genomics To Reduce Staff; Jean-Philippe Milon Becomes President and CEO

Quantum Genomics SA

22/02/2023 17:08

Feb 22 (Reuters) - Quantum Genomics SA  ALQGC.PA :
    * QUANTUM GENOMICS ANNOUNCES REORGANIZATION OF ITS BOARD OF
DIRECTORS AND STAFF RESTRUCTURATION IN ORDER TO FOCUS ON NEW
PROJECTS
    * BOARD OF DIRECTORS HAS THEN DECIDED TO REVOKE LIONEL
SÉGARD,
PRESIDENT AND FOUNDER OF QUANTUM GENOMICS
    * PROPOSED AND DECIDED APPOINTMENT OF JEAN-PHILIPPE MILON
(CEO OF
QUANTUM GENOMICS) AS PRESIDENT OF BOARD OF DIRECTORS, IN
ADDITION TO ITS CEO'S MANDATE
    * JEAN-PHILIPPE MILON IS NOW PRESIDENT AND CEO OF QUANTUM
GENOMICS
    * IMPLEMENTING PLAN TO RESTRUCTURE ITS WORKFORCE WHICH WILL
INVOLVE SUPPRESSION OF THOSE FUNCTIONS RELATED TO MARKETING AND
MARKET ACCESS OF FIRIBASTAT IN CARDIOLOGY
    * ENTERED INTO DISCUSSIONS WITH SEVERAL BIOTECH AND MEDTECH
COMPANIES
    * IS STUDYING ALL OPPORTUNITIES AND METHODS OF POSSIBLE
JOINT
VENTURES TO BUILD A NEW CORPORATE DEVELOPMENT PLAN
    * HAS SELECTED TWO PROJECTS, A BIOTECH COMPANY AND A MEDTECH
COMPANY, BOTH NON-LISTED
    * DISCUSSIONS ARE BEING CONDUCTED IN CLOSE COLLABORATION
WITH
OTIUM CAPITAL, COMPANY'S MAJOR SHAREHOLDER

Source text for Eikon:  ID:nACT78670 
Further company coverage:  ALQGC.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))